1. Board resolution date: 115/05/29. 2. Name and title of manager permitted to engage in competitive behavior: Lu Kong-Ming, Co-CEO. 3. Items of permitted competitive behavior: Chairman of Diamond High-Tech Investment, Diamond No. 1 Investment, Elite Investment, New Horizon Biotech Investment; Director of Oneness (Shanghai) Biotech, Oneness (HK) Biotech, Megabio Inc. (HK), Microbio Pharmaceutical; Chairman of Oneness (USA) Biotech. 4. Period: During his tenure as manager of the company. 5. Resolution status: Approved unanimously by all attending directors. 6. Engagement in Mainland China business: Lu Kong-Ming, Co-CEO. 7. Company name and title in Mainland China: Director of Oneness (Shanghai) Biotech. 8. Address: No. 1188, Guangxing Rd, Songjiang District, Shanghai. 9. Business scope: Pharmaceutical production, technology development, consulting, etc. 10. Impact on company: None. 11. Investment amount and shareholding ratio: US$5.705 million, 10.88%. 12. Other matters: None.
FACT BOX
- Source: PR Times
- Category: 人事管理
- Dates in source: 115/05/29